Paliperidone extended release: a review of its use in the management of schizophrenia

Drugs
Claudine M Chwieduk, Gillian M Keating

Abstract

Paliperidone, the major active metabolite of the atypical antipsychotic risperidone, is available in an oral extended-release (ER) formulation (Invega(R)) and is indicated for the acute and maintenance treatment of schizophrenia in adults in the US and the EU. Once-daily paliperidone ER provides stable plasma drug concentrations over a 24-hour period and may be initiated at therapeutically effective dosages without the need for titration. Paliperidone ER 3-12 mg/day improved Positive and Negative Syndrome Scale (PANSS) total scores (primary endpoint) from baseline to study end to a significantly greater extent than placebo in 6-week, double-blind trials in patients with acute symptoms of schizophrenia. The significant improvement in PANSS total score was seen after 4 days of treatment in some trials and paliperidone ER was effective against both positive and negative symptoms of the disease. End of treatment clinical response rates were significantly higher in paliperidone ER recipients than in those who received placebo. The efficacy of paliperidone ER was maintained with longer-term treatment (up to 52 weeks) in open-label extensions of placebo-controlled trials. When compared with quetiapine, paliperidone ER was associated w...Continue Reading

References

May 3, 2012·Psychopharmacology·Kimberly A StiglerChristopher J McDougle
Oct 12, 2012·Paediatric Drugs·Caroline M Perry
Feb 15, 2014·Journal of Clinical Psychopharmacology·Hung-Jen ChenHin-Yeung Tsang
Dec 15, 2012·Expert Review of Neurotherapeutics·Pierre ChueGlen B Baker
Dec 15, 2012·Expert Review of Neurotherapeutics·Pierre Chue, James Chue
May 14, 2011·Expert Opinion on Emerging Drugs·Falko Biedermann, W Wolfgang Fleischhacker
Mar 4, 2014·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·M E TsayB Anderson
May 5, 2012·The Journal of Emergency Medicine·Alicia B Minns, Richard F Clark
Dec 15, 2015·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·Esteban Sáez GonzálezJuan Antonio Ortuño Cortés
Jul 17, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kyoung-Sae NaChul-Eung Kim
Mar 2, 2016·Revista de psiquiatrí́a y salud mental·Ángel L MontejoEduard Vieta
Apr 30, 2017·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Erdinc CicekFaruk Uguz
Jan 13, 2016·Journal of Psychopharmacology·Min-Kyoung KimSang-Hyuk Lee
Jan 1, 2011·Journal of Central Nervous System Disease·Edoardo Spina, Rosalia Crupi

Citations

Jan 30, 2004·Diabetes Care·American Diabetes AssociationNorth American Association for the Study of Obesity
Feb 20, 2004·The International Journal of Neuropsychopharmacology·Ann M Mortimer
May 3, 2005·The American Journal of Psychiatry·Rikus KnegteringRobert J van den Bosch
Mar 4, 2006·The American Journal of Psychiatry·Gary RemingtonShitij Kapur
Apr 6, 2006·The AAPS Journal·Michael P Holt, Cynthia Ju
Dec 23, 2006·Clinical Pharmacology and Therapeutics·G A Fitzgerald
May 29, 2007·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
Jan 1, 2008·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Andreas TzimosMarielle Eerdekens
May 27, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Peter Falkai
Oct 29, 2008·Current Medical Research and Opinion·Natalie C EdwardsRiad Dirani
Nov 18, 2008·Journal of Psychiatric and Mental Health Nursing·A Jones
Jul 9, 2009·Pharmacopsychiatry·J BerwaertsMarielle Eerdekens
Jul 31, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·G MarcheseL Pani
Sep 11, 2009·CNS Drugs·Kayvon SalimiJeffrey A Lieberman
Sep 15, 2009·Primary Care Companion to the Journal of Clinical Psychiatry·Prakash S MasandJohn M Kane

Related Concepts

PRL
Antipsychotic Effect
Atypical Antipsychotic [EPC]
Olanzapine
Schizophrenia
Paliperidone
Extrapyramidal Sign
Recurrent Malignant Neoplasm
Antipsychotic Agents
Isoxazoles

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here